Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC -- Ignore unavailable to you. Want to Upgrade?

To: Harold S. who wrote (1179)	4/20/1998 5:40:00 PM
From: muddphudd	Respond to of 1359

Yes, there were 2 phase III studies that showed efficacy. I was just on the Yahoo thread. Neuroinvest said that apparently the results of the MRI study revealed today was plagued by unusual results in the placebo control group. How that will pan out I don't know. Though I am still in shock, at least it wasn't the FDA that killed CerAxon. Maybe it still has life! Lets hope. I didn't sell any shares today. Long (perhaps silly) on IPIC.

To: Harold S. who wrote (1179)	4/20/1998 5:41:00 PM
From: muddphudd	Read Replies (2) \| Respond to of 1359

As to when to jump in....I would wait to let people relax after the news. It may take a week or two for things to calm down. See where the stock is then and reassess. Lets hope we get some word from the company.

To: Harold S. who wrote (1179)	4/24/1998 7:59:00 PM
From: muddphudd	Read Replies (1) \| Respond to of 1359

What I would like to know is what is the face value of IPIC right now. I was looking at the Briefing Book on the Wall Street Journal website. It says there are 41 million outstanding shares and assets of $126 million. Does that make IPIC worth $3 per share WITHOUT taking into account its pipeline? If anyone could clear this up for me I would appreciate it very much. I am considering averaging-down but I want to know what the absolute bottom price could be. Thanks.